RFK Jr.'s dismissal of vaccine science during Senate hearings raises concerns about his fitness for HHS secretary role.
Kennedy eventually dropped out of the race to endorse Trump, who then nominated him for HHS secretary. Since joining Trump, Kennedy has focused on a "Make America Healthy Again" slogan ...
MSNBC’s Lawrence O’Donnell details how Caroline Kennedy’s condemnation of RFK Jr. is the “most important” public statement made about any Trump nominee in which she urged senators to ...
Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...
We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...
The U.S. Department of Health and Human Services at 200 Independence Ave. SW in Washington, DC. The agency, which has some 90,000 employees, is putting a freeze on most staff communication as of ...
HHS Secretary Alex Azar listens at right. (AP Photo/Susan Walsh, file) President Donald Trump speaks to members of the press as Director Robert Redfield, right, looks at the headquarters of the ...
HHS Sec­re­tary nom­i­nee Robert F. Kennedy Jr. will di­vest his in­ter­ests in sev­er­al bio­phar­ma com­pa­nies, in­clud­ing CRISPR Ther­a­peu­tics and Drag­on­fly Ther­a ...
The memo, which was sent to agency leaders by acting HHS Secretary Dorothy Fink, outlines that the HHS agencies should refrain from sending any documents for publication in the Federal Register ...
Kennedy Jr., President-elect Donald Trump’s pick for HHS secretary, undergoes Senate confirmation. Kennedy’s confirmation hearings are still not scheduled, and he is facing bipartisan pressure ...
The first direction Tuesday was given by Stefanie Spear, a deputy chief of staff at HHS who joined the agency this week, according to the Post. Spear was the press secretary for Robert F.
TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...